Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Sun Yat-san University Cancer Center, Guangzhou, Guangdong, China
4th Military Clinical Hospital with Polyclinic, Wrocław, Dolnośląskie, Poland
Taipei Veterans General Hospital, Taipei, Taiwan
First hospital of China Mdical University, Shenyang, Liaoning, China
First Hospital of China Medical University, Shenyang, Liaoning, China
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Tongji Hospital, Wuhan, Hubei, China
The third Xiangya Hospital of Central South University, Changsha, Hunan, China
Umraniye Education and Research hospital, Istanbul, Turkey
American University of Beirut Medical Center, Beirut, Lebanon
Ain Shams university, Cairo, Abbaseya, Egypt
PROSOMNIA Sleep Health and Wellness, Aventura, Florida, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.